0001415889-24-007188.txt : 20240307
0001415889-24-007188.hdr.sgml : 20240307
20240307163110
ACCESSION NUMBER: 0001415889-24-007188
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240305
FILED AS OF DATE: 20240307
DATE AS OF CHANGE: 20240307
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NEWELL WILLIAM J
CENTRAL INDEX KEY: 0001309660
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38662
FILM NUMBER: 24730621
MAIL ADDRESS:
STREET 1: 887 GREAT NORTHERN WAY
CITY: VANCOUVER
STATE: A1
ZIP: V5T 4T5
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SUTRO BIOPHARMA, INC.
CENTRAL INDEX KEY: 0001382101
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 452441988
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 111 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-392-8412
MAIL ADDRESS:
STREET 1: 111 OYSTER POINT BLVD.
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
FORMER COMPANY:
FORMER CONFORMED NAME: SUTRO BIOPHARMA INC
DATE OF NAME CHANGE: 20061127
4
1
form4-03072024_090300.xml
X0508
4
2024-03-05
0001382101
SUTRO BIOPHARMA, INC.
STRO
0001309660
NEWELL WILLIAM J
C/O SUTRO BIOPHARMA, INC.
111 OYSTER POINT BLVD.
SOUTH SAN FRANCISCO
CA
94080
true
true
false
false
CEO
0
Common Stock
2024-03-05
4
M
0
18750
0
A
226893
D
Common Stock
2024-03-05
4
F
0
6690
4.54
D
220203
D
Common Stock
116525
I
By William J. Newell Family Trust DTD 03/15/2019
Stock Option (Right to Buy Common Stock)
4.54
2024-03-05
4
A
0
174000
0
A
2034-03-05
Common Stock
174000
174000
D
Restricted Stock Units (RSUs)
2024-03-05
4
A
0
130500
0
A
2028-03-01
Common Stock
130500
130500
D
Restricted Stock Unit (RSU)
2024-03-05
4
M
0
18750
0
D
2025-03-05
Common Stock
18750
18750
D
Represents the number of shares of Common Stock that have been withheld by the issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of restricted stock units; does not represent a sale by the reporting person.
The securities are held of record by the reporting person as trustee of the William J. Newell Family Trust DTD 03/15/2019.
The option vests as to 2.0833% of the total award monthly, beginning on April 1, 2024, with 100% of the award being vested and exercisable on March 1, 2028, subject to the reporting person's continued service to the Issuer on each vesting date.
Each RSU represents a contingent right to receive one (1) share of the Issuer's Common Stock upon settlement.
The RSUs vest as to 1/4th of the total award annually beginning on March 1, 2025, subject to continued service through each vesting date.
The RSUs vest as to 1/4th of the total award annually beginning on March 5, 2022, subject to continued service through each vesting date.
/s/ Edward C. Albini as attorney-in-fact for William J. Newell
2024-03-07